Polypeptide Therapeutic Solutions (PTS) Announces Company Name Change to Curapath and Expansion of Drug Delivery Capabilities and Services
yahoo.com
news
2022-10-17 06:00:00

Expanded capabilities support development and production of novel functional lipid excipients and nanoparticle formulation

Addition of late stage clinical and commercial-scale production is also planned

Company to present on shielding lipid novel excipients for lipid nanoparticle (LNP) formulations at Lipid Nanoparticles Development Summit on October 20th

VALENCIA, Spain & BOSTON, October 17, 2022--(BUSINESS WIRE)--Polypeptide Therapeutic Solutions (PTS), a leader in the design, development, and custom manufacturing of polyamino-acid based delivery systems for vaccines and therapeutics, today announced the company has changed its name to Curapath.
